UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024796
Receipt number R000028529
Scientific Title Evaluation of po suvorexant for delirium in ICU ventilated patients
Date of disclosure of the study information 2016/11/11
Last modified on 2017/11/22 14:27:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of po suvorexant for delirium in ICU ventilated patients

Acronym

Evaluation of po suvorexant in ICU patients

Scientific Title

Evaluation of po suvorexant for delirium in ICU ventilated patients

Scientific Title:Acronym

Evaluation of po suvorexant in ICU patients

Region

Japan


Condition

Condition

insomnia

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy and safety of administration of suvorexant via gastric tube in ICU.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

frequency of insomnia, dose of sedative agents

Key secondary outcomes

frequency of delirium, dose of vasopressor


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of suborexant via gastric tube(half dose)

Interventions/Control_2

Administration of suborexant via gastric tube

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patient who need mechanical ventilation and expected to stay ICU for 24 hours

Key exclusion criteria

・Severe liver disfunction
・Patient who need continuous sedation throughout day
・Gastrointestinal dysfunction

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kansuke Koyama

Organization

Jichi Medical University hospital

Division name

Department of Anesthesiology and Intensive care Medicine

Zip code


Address

3311-1 Yakushiji Shimotsuke-shi, Tochigi

TEL

0285-58-7392

Email

k_koyama@jichi.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kansuke Koyama

Organization

Jichi Medical University hospital

Division name

Department of Anesthesiology and Intensive care Medicine

Zip code


Address

3311-1 Yakushiji Shimotsuke-shi, Tochigi

TEL

0285-58-7392

Homepage URL


Email

k_koyama@jichi.ac.jp


Sponsor or person

Institute

Jichi Medical university hospital

Institute

Department

Personal name



Funding Source

Organization

Jichi Medical university hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 11 Month 11 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 14 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 11 Month 11 Day

Last modified on

2017 Year 11 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028529


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name